These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1155 related items for PubMed ID: 19647632

  • 1. Reducing the risk of xerostomia and mandibular osteoradionecrosis: the potential benefits of intensity modulated radiotherapy in advanced oral cavity carcinoma.
    Ahmed M, Hansen VN, Harrington KJ, Nutting CM.
    Med Dosim; 2009; 34(3):217-24. PubMed ID: 19647632
    [Abstract] [Full Text] [Related]

  • 2. Significant improvement in normal tissue sparing and target coverage for head and neck cancer by means of helical tomotherapy.
    Fiorino C, Dell'Oca I, Pierelli A, Broggi S, De Martin E, Di Muzio N, Longobardi B, Fazio F, Calandrino R.
    Radiother Oncol; 2006 Mar; 78(3):276-82. PubMed ID: 16546279
    [Abstract] [Full Text] [Related]

  • 3. Osteoradionecrosis of the mandible: minimized risk profile following intensity-modulated radiation therapy (IMRT).
    Studer G, Studer SP, Zwahlen RA, Huguenin P, Grätz KW, Lütolf UM, Glanzmann C.
    Strahlenther Onkol; 2006 May; 182(5):283-8. PubMed ID: 16673062
    [Abstract] [Full Text] [Related]

  • 4. Intensity-modulated radiotherapy improves target coverage, spinal cord sparing and allows dose escalation in patients with locally advanced cancer of the larynx.
    Clark CH, Bidmead AM, Mubata CD, Harrington KJ, Nutting CM.
    Radiother Oncol; 2004 Feb; 70(2):189-98. PubMed ID: 15028407
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Preservation of oral health-related quality of life and salivary flow rates after inverse-planned intensity- modulated radiotherapy (IMRT) for head-and-neck cancer.
    Parliament MB, Scrimger RA, Anderson SG, Kurien EC, Thompson HK, Field GC, Hanson J.
    Int J Radiat Oncol Biol Phys; 2004 Mar 01; 58(3):663-73. PubMed ID: 14967418
    [Abstract] [Full Text] [Related]

  • 8. Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord.
    Chau RM, Teo PM, Kam MK, Leung SF, Cheung KY, Chan AT.
    Med Dosim; 2007 Mar 01; 32(4):263-70. PubMed ID: 17980826
    [Abstract] [Full Text] [Related]

  • 9. Dosimetry and radiobiologic model comparison of IMRT and 3D conformal radiotherapy in treatment of carcinoma of the prostate.
    Luxton G, Hancock SL, Boyer AL.
    Int J Radiat Oncol Biol Phys; 2004 May 01; 59(1):267-84. PubMed ID: 15093924
    [Abstract] [Full Text] [Related]

  • 10. Implications of radiation dosimetry of the mandible in patients with carcinomas of the oral cavity and nasopharynx treated with intensity modulated radiation therapy.
    Parliament M, Alidrisi M, Munroe M, Wolfaardt J, Scrimger R, Thompson H, Field C, Kurien E, Hanson J.
    Int J Oral Maxillofac Surg; 2005 Mar 01; 34(2):114-21. PubMed ID: 15695037
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Intensity-modulated vs. conformal radiotherapy of parotid gland tumors: potential impact on hearing loss.
    Lamers-Kuijper E, Schwarz M, Rasch C, Mijnheer B.
    Med Dosim; 2007 Mar 01; 32(4):237-45. PubMed ID: 17980823
    [Abstract] [Full Text] [Related]

  • 15. Optimization of radiation therapy for locally advanced adenoid cystic carcinomas with infiltration of the skull base using photon intensity-modulated radiation therapy (IMRT) and a carbon ion boost.
    Schulz-Ertner D, Didinger B, Nikoghosyan A, Jäkel O, Zuna I, Wannenmacher M, Debus J.
    Strahlenther Onkol; 2003 May 01; 179(5):345-51. PubMed ID: 12740662
    [Abstract] [Full Text] [Related]

  • 16. Importance of the initial volume of parotid glands in xerostomia for patients with head and neck cancers treated with IMRT.
    Nishimura Y, Nakamatsu K, Shibata T, Kanamori S, Koike R, Okumura M, Suzuki M.
    Jpn J Clin Oncol; 2005 Jul 01; 35(7):375-9. PubMed ID: 15976068
    [Abstract] [Full Text] [Related]

  • 17. Intraindividual comparison of conventional three-dimensional radiotherapy and intensity modulated radiotherapy in the therapy of locally advanced non-small cell lung cancer a planning study.
    Marnitz S, Stuschke M, Bohsung J, Moys A, Reng I, Wurm R, Budach V.
    Strahlenther Onkol; 2002 Nov 01; 178(11):651-8. PubMed ID: 12426677
    [Abstract] [Full Text] [Related]

  • 18. Feasibility of sparing lung and other thoracic structures with intensity-modulated radiotherapy for non-small-cell lung cancer.
    Liu HH, Wang X, Dong L, Wu Q, Liao Z, Stevens CW, Guerrero TM, Komaki R, Cox JD, Mohan R.
    Int J Radiat Oncol Biol Phys; 2004 Mar 15; 58(4):1268-79. PubMed ID: 15001272
    [Abstract] [Full Text] [Related]

  • 19. Dynamic intensity-modulated non-coplanar arc radiotherapy (INCA) for head and neck cancer.
    Krayenbuehl J, Davis JB, Ciernik IF.
    Radiother Oncol; 2006 Nov 15; 81(2):151-7. PubMed ID: 17055095
    [Abstract] [Full Text] [Related]

  • 20. Obtaining normal tissue constraints using intensity modulated radiotherapy (IMRT) in patients with oral cavity, oropharyngeal, and laryngeal carcinoma.
    Skinner WK, Muse ED, Yaparpalvi R, Guha C, Garg MK, Kalnicki S.
    Med Dosim; 2009 Nov 15; 34(4):279-84. PubMed ID: 19854386
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 58.